Dave Helsel - Aug 12, 2021 Form 4/A - Amendment Insider Report for ANGIODYNAMICS INC (ANGO)

Role
SVP Global Operations and R&D
Signature
/s/ Richard C. Rosenzweig, Attorney in Fact
Stock symbol
ANGO
Transactions as of
Aug 12, 2021
Transactions value $
-$91,340
Form type
4/A - Amendment
Date filed
8/18/2021, 06:59 AM
Date Of Original Report
Aug 17, 2021
Previous filing
Dec 30, 2021
Next filing
Oct 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGO Common Stock Options Exercise $0 +11.4K +52.27% $0.00 33.2K Aug 12, 2021 Direct F1, F2
transaction ANGO Common Stock Tax liability -$91.3K -3.35K -10.07% $27.29 29.9K Aug 12, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANGO Performance Right Options Exercise $0 -9.83K -100% $0.00* 0 Aug 12, 2021 Common Stock 9.83K Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 17, 2021, the reporting person filed a Form 4 to report the vesting and settlement of performance share units and the sale of certain underlying shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), which contained administrative errors as to the terms of the performance share units and the number of shares of Common Stock of the Company issued and sold.
F2 This acquisition of 11,406 shares of Common Stock of the Company represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 18, 2018.
F3 The exempt disposition of 3,347 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 18, 2018.
F4 On July 18, 2018, the reporting person received a target grant of 9,834 performance share units. Between 0% and 200% of the target number was to be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Based on performance over the period, 11,406 shares of Common Stock were issued to the reporting person under this grant.